I do agree though that if they can survive the medium term without running out of investors or selling entirely to the chinese there are some good long term gains to be had given the steady growth in ADAPT and the TAVR possibilities - the vax may even be worth something (probably not).
- Forums
- ASX - By Stock
- Ann: Trading Halt
I do agree though that if they can survive the medium term...
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.10 |
Change
-0.810(8.17%) |
Mkt cap ! $192.3M |
Open | High | Low | Value | Volume |
$9.50 | $9.77 | $9.01 | $212.2K | 22.63K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 298 | $9.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.85 | 1000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 298 | 9.010 |
1 | 1000 | 9.000 |
1 | 200 | 8.700 |
1 | 200 | 8.500 |
2 | 200 | 8.000 |
Price($) | Vol. | No. |
---|---|---|
9.850 | 1000 | 1 |
9.910 | 231 | 2 |
10.000 | 10250 | 2 |
10.200 | 545 | 1 |
10.500 | 10000 | 1 |
Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online